This contraindication applies to semaglutide (Ozempic, Wegovy, Rybelsus), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), exenatide extended-release (Bydureon BCise), tirzepatide (Mounjaro, Zepbound), and the combination product Xultophy (insulin degludec/liraglutide)
Two huge reasons: Extended Half-Life: Standard IGF-1 has a half-life of only about 10-20 minutes
Additionally, it is linked to poor diet or certain long-term health conditions where the body struggles to maintain adequate carnitine levels on its own
Find out more at urbanwellness.co.uk
Like Ozempic, Trulicity also reduces the risk that people with type 2 diabetes both with and without heart disease will experience a major cardiac event such as stroke, heart attack , or cardiovascular death